Pharma Stocks
-
We’re Keeping An Eye On Cocrystal Pharma’s (NASDAQ:COCP) Cash Burn Rate
Just because a business does not make any money, does not mean that the stock will go down. For example,…
Read More » -
We’re Keeping An Eye On Cocrystal Pharma’s (NASDAQ:COCP) Cash Burn Rate
There’s no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses…
Read More » -
Assessing Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After New SUBLOCADE Cost Savings Evidence In Corrections Settings
Indivior Pharmaceuticals (INDV) is back in focus after a new peer reviewed cost impact model suggested its monthly SUBLOCADE injection…
Read More » -
How Investors Are Reacting To PTC Therapeutics (PTCT) Adding Veteran Dealmaker Jessica Chutter To Its Board
PTC Therapeutics recently appointed longtime Morgan Stanley healthcare banker Jessica Chutter to its Board of Directors as a Class I…
Read More » -
Brazil’s pharma powerhouse worth your watch?
Ever wondered how a Brazilian drugmaker stacks up in a global market dominated by U.S. giants? For North American investors…
Read More » -
Why it’s a biotech powerhouse you can’t ignore
Is Regeneron Pharma’s innovative pipeline enough to drive long-term gains in a volatile biotech sector? For North American investors, this…
Read More » -
Strong margins amid shifting pharma winds
You’re eyeing Merck & Co., Inc. as a pharma powerhouse— but what drives its edge in a competitive market? This…
Read More » -
Pharma calls in sick after Trump’s 100% tariff threat
Pharma stocks fell Thursday after reports of US President Donald Trump mulling 100% tariffs on imported branded and patented medicine…
Read More » -
Is Johnson & Johnson (JNJ) Still Attractive After Strong 1-Year Share Price Performance?
If you are wondering whether Johnson & Johnson is priced for perfection or still offers value, its recent share performance…
Read More » -
Is Amgen Inc. (AMGN) One of the Best Pharma Stocks to Invest in Now?
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off…
Read More »